Stories this photo appears in:
ALS drug Relyvrio withdrawn from market; clinical trial fails
Amylyx Pharmaceuticals announced Thursday that it has begun the process of voluntarily withdrawing its ALS drug, Relyvrio, from the market after it failed to prove efficacy in a large clinical trial.
